Page last updated: 2024-08-26

nimbolide and Lung Neoplasms

nimbolide has been researched along with Lung Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Andugulapati, SB; Jadav, SS; Manga, B; Ramalingam, V; Sudeshna, K; Suresh Babu, K; Venkateswara Rao, B1
Lin, H; Liu, C; Qiu, S; Sun, S; Xie, L1
Aggarwal, BB; Gupta, SC; Hema, PS; Nair, M; Park, B; Phromnoi, K; Reuter, S1

Other Studies

3 other study(ies) available for nimbolide and Lung Neoplasms

ArticleYear
Design, synthesis and cytotoxic activity studies of alkyne linked analogues of Nimbolide.
    Fitoterapia, 2022, Volume: 161

    Topics: Alkynes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Limonins; Lung Neoplasms; Molecular Docking Simulation; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship

2022
Nimbolide suppresses non-small cell lung cancer cell invasion and migration via manipulation of DUSP4 expression and ERK1/2 signaling.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 92

    Topics: A549 Cells; Azadirachta; Carcinoma, Non-Small-Cell Lung; Cell Movement; Dose-Response Relationship, Drug; Dual-Specificity Phosphatases; Gene Expression Regulation, Neoplastic; Humans; Limonins; Lung Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Phosphatases; Neoplasm Invasiveness

2017
Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
    The Journal of biological chemistry, 2011, Jan-14, Volume: 286, Issue:2

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Breast Neoplasms; Colonic Neoplasms; Extracellular Signal-Regulated MAP Kinases; HCT116 Cells; HT29 Cells; Humans; Kidney Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Limonins; Lung Neoplasms; Multiple Myeloma; Pancreatic Neoplasms; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Tumor Suppressor Protein p53

2011